by MM360 Staff | Jun 17, 2025 | Myeloma News
Source: Pharmacy Times articles Talquetamab and teclistamab showed significant promise in a phase 1b/2 dose escalation and expansion trial. Read More
by MM360 Staff | Jun 13, 2025 | Publications
Leuk Lymphoma. 2025 Jun 12:1-11. doi: 10.1080/10428194.2025.2512031. Online ahead of print. ABSTRACT THIS META-ANALYSIS OF EIGHT PHASE 3 RCTS ASSESSED EFFICACY AND SAFETY OF ANTI-CD38 MONOCLONAL ANTIBODIES (MABS) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA...
by MM360 Staff | Jun 10, 2025 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by MM360 Staff | Jun 9, 2025 | Uncategorized
Source: CureToday articles Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship. Read More
by MM360 Staff | Jun 9, 2025 | Myeloma News
Source: Pharmacy Times articles Cilta-cel shows promise as a CAR T-cell therapy, offering long-term remission for relapsed/refractory multiple myeloma patients without maintenance treatment. Read More
